Polski Bank Komórek Macierzystych S.A. (WSE:BKM) entered into a memorandum of understanding to acquire Cryo-Save Family Stem Cell Banking business from Esperite N.V. (ENXTAM:ESP) for €10 million on February 22, 2019. The consideration is dependent upon the outcome of due diligence and assumption of liabilities. The transaction is subject to Polski Bank conducting legal, financial, tax and commercial due diligence, signing of definitive agreement, approval from the shareholders of Esperite and approval from the supervisory board of Polski Bank.

Polski Bank Komórek Macierzystych S.A. (WSE:BKM) cancelled the acquisition of Cryo-Save Family Stem Cell Banking business from Esperite N.V. (ENXTAM:ESP) on May 28, 2019. This is due to parties' lack of agreement on the terms of the sale. As a result, the exclusivity granted by Esperite to Polski Bank Komórek Macierzystych S.A. in relation to the proposed sale also terminated with immediate effect.